It may promote neural repair, enhance brain plasticity, and support overall neurological health
Drug reactions account for 80% of cases, with antibiotics (sulfonamides, penicillins), anticonvulsants (phenytoin, carbamazepine), and NSAIDs being the most common triggers within 1-8 weeks of starting medication
As one 2025 review put it, "to date, no published in vivo data demonstrate that BPC 157 inhibits tumor progression, reduces tumor volume, or suppresses metastasis" [16]
GHK-Cu may be the more relevant option when the goal includes broader skin, scalp, collagen, or tissue support
Think clearer skin, better recovery, and that subtle glow that builds with consistency
Besides neonates, they both can be used for the rest of the population including pediatrics, adults and the geriatric community